跳至主要内容
临床试验/NCT00674453
NCT00674453已完成2 期

The Effect Of Lasofoxifene On Local Mediators Of Bone Resorption In The Prevention Of Postmenopausal Osteoporosis

Ligand Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2004年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
51
试验地点
1
主要终点
Change in bone mineral density of the lumbar spine.

研究概览

简要总结

The objective of the study is to demonstrate the effects that lasofoxifene has on serum markers of bone metabolism.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women over 50 years who have low bone mineral density.

排除标准

  • Women who are under 50 years of age, are premenopausal, or who currently have osteoporosis are excluded.

研究组 & 干预措施

Lasofoxifene 0.25 mg/d

Experimental

干预措施: Lasofoxifene (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Other)

结局指标

主要结局

Change in bone mineral density of the lumbar spine.

时间窗: 2 years

次要结局

  • The secondary outcomes are the levels of cells and proteins in the blood that provide information about the health of bone, along with change in bone mineral density of the hip and forearm.(2 years)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验